MRI scans significantly change target coverage decisions in radical radiotherapy for prostate cancer-Reference-Cited by-同舟云学术

MRI scans significantly change target coverage decisions in radical radiotherapy for prostate cancer

Published:2013-08-29 Issue:2 Volume:58 Page:237-243
ISSN:1754-9477
Container-title:Journal of Medical Imaging and Radiation Oncology
language:en
Short-container-title:Journal of Medical Imaging and Radiation Oncology

Author:

Chang Joe H.¹²³,Lim Joon Daryl¹³,Nguyen Brandon T.¹,Hiew Chee-Yan⁴,Esler Stephen⁴,Angus David⁵,Chao Michael⁶,Wada Morikatsu¹,Quong George⁶,Khoo Vincent¹³⁷

Affiliation:

1. Radiation Oncology Centre; Austin Health; Melbourne Victoria Australia

2. Division of Radiation Oncology and Cancer Imaging; Peter MacCallum Cancer Centre; Melbourne Victoria Australia

3. University of Melbourne; Melbourne Victoria Australia

4. Department of Radiology; Austin Health; Melbourne Victoria Australia

5. Department of Urology; Austin Health; Melbourne Victoria Australia

6. Radiation Oncology Victoria; Melbourne Victoria Australia

7. Department of Clinical Oncology; Royal Marsden Hospital Trust & Institute of Cancer Research; London UK

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference35 articles.

1. NCCN clinical practice guidelines in oncology: prostate cancer;Mohler;J Natl Compr Canc Netw,2010

2. Heidenreich A Bolla M Joniau S et al Guidelines on prostate cancer 2011 http://www.uroweb.org/gls/pdf/08_Prostate_Cancer.pdf

3. Is a digital rectal examination necessary in the diagnosis and clinical staging of early prostate cancer?;Philip;BJU Int,2005

4. Interexaminer variability of digital rectal examination in detecting prostate cancer;Smith;Urology,1995

5. Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial;Smith;J Urol,1997

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Smart bismuth-based platform: A focus on radiotherapy and multimodal systems;Journal of Drug Delivery Science and Technology;2024-11

2. Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancer;World Journal of Urology;2023-11-15

3. Development and implementation of optimized endogenous contrast sequences for delineation in adaptive radiotherapy on a 1.5T MR-linear-accelerator: a prospective R-IDEAL stage 0-2a quantitative/qualitative evaluation of in vivo site-specific quality-assurance using a 3D T2 fat-suppressed platform fo;Journal of Medical Imaging;2023-11-06

4. Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future Directions;Cancers;2023-03-30

5. Development and implementation of optimized endogenous contrast sequences for delineation in adaptive radiotherapy on a 1.5T MR-Linear-accelerator (MR-Linac): A prospective R-IDEAL Stage 0-2a quantitative/qualitative evaluation of in vivo site-specific quality-assurance using a 3D T2 fat-suppressed platform for head and neck cancer;2022-06-27